OTOTOXICITY, DRUG-INDUCED
Clinical trials for OTOTOXICITY, DRUG-INDUCED explained in plain language.
Never miss a new study
Get alerted when new OTOTOXICITY, DRUG-INDUCED trials appear
Sign up with your email to follow new studies for OTOTOXICITY, DRUG-INDUCED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Simple supplement may shield cancer patients from permanent hearing loss
Prevention Recruiting nowThis study tests whether N-acetylcysteine (NAC), a widely available supplement, can prevent the permanent hearing loss often caused by the chemotherapy drug cisplatin. About 40 adults receiving high-dose cisplatin will be randomly assigned to take NAC or a placebo during their tr…
Matched conditions: OTOTOXICITY, DRUG-INDUCED
Phase: PHASE2 • Sponsor: Siriraj Hospital • Aim: Prevention
Last updated May 26, 2026 04:38 UTC
-
New drug aims to stop Antibiotic-Related hearing loss
Prevention Recruiting nowThis study tests if the drug ORC-13661 can prevent hearing loss in people receiving IV amikacin for a lung infection called NTM. About 105 adults will take either a low dose, high dose, or placebo pill for up to 90 days. Researchers will compare hearing changes among the groups t…
Matched conditions: OTOTOXICITY, DRUG-INDUCED
Phase: PHASE2 • Sponsor: Kevin Winthrop • Aim: Prevention
Last updated May 20, 2026 11:55 UTC
-
Hearing aids offer hope for Chemotherapy-Induced hearing loss
Symptom relief Recruiting nowThis study looks at whether hearing aids can improve the quality of life for cancer patients who develop hearing problems from platinum-based chemotherapy. About 52 adults currently receiving such chemotherapy and experiencing hearing loss will be offered a hearing aid. Researche…
Matched conditions: OTOTOXICITY, DRUG-INDUCED
Phase: NA • Sponsor: Institut de Cancérologie de Lorraine • Aim: Symptom relief
Last updated May 14, 2026 12:03 UTC